BlackRock Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

BlackRock Group’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.48M	Sell	63,210 -15,549	-20%	-$853K	﹤0.01%	1390
2016 Q3	$4.45M	Buy	78,759 +58,789	+294%	+$2.88M	﹤0.01%	1164
2016 Q2	$833K	Buy	19,970 +12,492	+167%	+$576K	﹤0.01%	2052
2016 Q1	$320K	Buy	7,478 +1,748	+31%	+$73.9K	﹤0.01%	2409
2015 Q4	$259K	Sell	5,730 -12,722	-69%	-$534K	﹤0.01%	2443
2015 Q3	$718K	Sell	18,452 -3,461	-16%	-$139K	﹤0.01%	2063
2015 Q2	$796K	Sell	21,913 -11,337	-34%	-$359K	﹤0.01%	2075
2015 Q1	$960K	Buy	33,250 +8,511	+34%	+$237K	﹤0.01%	1893
2014 Q4	$599K	Buy	+24,739	New	+$558K	﹤0.01%	2163

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

BlackRock Group's PRAH Position: Q4 2016 in Review

BlackRock Group reduced its PRA Health Sciences, Inc. (PRAH) stake by 20% in Q4 2016, selling an estimated $853K and leaving 63,210 shares worth $3.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1390.

BlackRock Group first reported a position in PRAH in Q4 2014 and has held it in 9 quarters since. The position peaked at $4.45M in Q3 2016. 188 funds tracked by Wall St. Rank hold PRAH as of Q4 2016.

BlackRock Group held 63,210 shares of PRA Health Sciences, Inc. worth $3.48M as of Q4 2016.
BlackRock Group sold 15,549 PRA Health Sciences, Inc. shares in Q4 2016, an estimated $853K.
PRA Health Sciences, Inc. made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1390 holding.
BlackRock Group first reported a position in PRA Health Sciences, Inc. in Q4 2014 and has held it in 9 quarters since.
BlackRock Group's PRA Health Sciences, Inc. position peaked at $4.45M in Q3 2016.
188 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.